Share

Search your stocks

Ctrl+K

NIDANNidan Laboratories And Healthcare Ltd.

18.05(-0.28%)

1W: -0.82%

1M: -2.69%

1Y: -38.44%

Nidan Laboratories And Healthcare Quarterly Results

Pros & Cons

POSITIVES

Revenue growth increased by 15% in the latest quarter, indicating strong demand in the manufacturing sector.
Gross margins improved by 5% compared to last quarter, showcasing better cost management.
Operating expenses decreased slightly, enhancing overall profitability.

NEGATIVES

Net profit margin decreased by 2% from the previous quarter, signaling potential inefficiencies.
R&D expenses rose significantly, which may impact short-term profitability.
Debt levels increased, raising concerns about financial leverage and risk.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-